CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($) $ in Millions	Total	Total Dentsply Sirona Equity	Common Stock	Capital in Excess of Par Value	Accumulated Deficit Retained Earnings	Accumulated Other Comprehensive Loss	Treasury Stock	Noncontrolling Interests
Beginning Balance at Dec. 31, 2023	$ 3,294	$ 3,293	$ 3	$ 6,643	$ 205	$ (636)	$ (2,922)	$ 1
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	17	18			18			(1)
Other comprehensive income (loss)	(30)	(30)				(30)
Stock-based compensation expense	11	11		11
Funding of employee stock purchase plan	3	3					3
Restricted stock unit distributions	(4)	(4)		(15)			11
Cash dividends declared ($0.16 per share)	(33)	(33)			(33)
Ending Balance at Mar. 31, 2024	3,258	3,258	3	6,639	190	(666)	(2,908)	0
Beginning Balance at Dec. 31, 2023	3,294	3,293	3	6,643	205	(636)	(2,922)	1
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(482)
Other comprehensive income (loss)	(2)
Ending Balance at Sep. 30, 2024	2,490	2,491	3	6,639	(374)	(638)	(3,139)	(1)
Beginning Balance at Mar. 31, 2024	3,258	3,258	3	6,639	190	(666)	(2,908)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(4)	(4)			(4)
Other comprehensive income (loss)	(11)	(11)				(11)
Stock-based compensation expense	12	12		12
Treasury shares purchased	(152)	(152)					(152)
Restricted stock unit distributions	(5)	(5)		(20)			15
Cash dividends declared ($0.16 per share)	(34)	(34)			(34)
Ending Balance at Jun. 30, 2024	3,064	3,064	3	6,631	152	(677)	(3,045)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(495)	(494)			(494)			(1)
Other comprehensive income (loss)	39	39				39
Stock-based compensation expense	12	12		12
Funding of employee stock purchase plan	3	3		(2)			5
Treasury shares purchased	(101)	(101)					(101)
Restricted stock unit distributions	(1)	(1)		(3)			2
Restricted stock unit dividends	0			1	(1)
Cash dividends declared ($0.16 per share)	(31)	(31)			(31)
Ending Balance at Sep. 30, 2024	2,490	2,491	3	6,639	(374)	(638)	(3,139)	(1)
Beginning Balance at Dec. 31, 2024	1,943	1,942	3	6,640	(835)	(730)	(3,136)	1
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	19	20			20			(1)
Other comprehensive income (loss)	71	71				71
Stock-based compensation expense	10	10		10
Funding of employee stock purchase plan	2	2		(3)			5
Restricted stock unit distributions	(3)	(3)		(17)			14
Restricted stock unit dividends	0			1	(1)
Cash dividends declared ($0.16 per share)	(32)	(32)			(32)
Ending Balance at Mar. 31, 2025	2,010	2,010	3	6,631	(848)	(659)	(3,117)	0
Beginning Balance at Dec. 31, 2024	1,943	1,942	3	6,640	(835)	(730)	(3,136)	1
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(453)
Other comprehensive income (loss)	58
Ending Balance at Sep. 30, 2025	1,478	1,478	3	6,638	(1,385)	(672)	(3,106)	0
Beginning Balance at Mar. 31, 2025	2,010	2,010	3	6,631	(848)	(659)	(3,117)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(44)	(45)			(45)			1
Other comprehensive income (loss)	18	18				18
Stock-based compensation expense	9	9		9
Restricted stock unit distributions	0			(2)			2
Cash dividends declared ($0.16 per share)	(32)	(32)			(32)
Ending Balance at Jun. 30, 2025	1,961	1,960	3	6,638	(925)	(641)	(3,115)	1
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(428)	(427)			(427)			(1)
Other comprehensive income (loss)	(31)	(31)				(31)
Stock-based compensation expense	6	6		6
Funding of employee stock purchase plan	2	2		(4)			6
Restricted stock unit distributions	0			(3)			3
Restricted stock unit dividends	0			1	(1)
Cash dividends declared ($0.16 per share)	(32)	(32)			(32)
Ending Balance at Sep. 30, 2025	$ 1,478	$ 1,478	$ 3	$ 6,638	$ (1,385)	$ (672)	$ (3,106)	$ 0